Road to Hepatitis C Elimination in Israel: Improvements in Linkage to Care (2009–2020)
Real-world data from a nationally representative healthcare provider database suggest that HCV linkage to care improved over time alongside increased access to DAAs, despite observed declines in access to care in 2020.
Authors
- Steven E. Marx (ORCID: https://orcid.org/0000-0002-2171-1923)
- Clara Weil (ORCID: https://orcid.org/0000-0002-0174-7208)
- Oren Shibolet (ORCID: https://orcid.org/0000-0003-0081-3872)
- Douglas E. Dylla (ORCID: https://orcid.org/0000-0003-1991-127X)
- Daniella Rahamim-Cohen
- Michelle Collins (ORCID: https://orcid.org/0000-0002-1693-3265)
- Annalie Basson (ORCID: https://orcid.org/0000-0002-0387-4614)
- Sapir Hadadi
- Gabriel Chodick (ORCID: https://orcid.org/0000-0002-5189-8995)
- I. Lavi
Institutions
- Tel Aviv University (IL)
- AbbVie (United States) (US)
- Roche (Israel) (IL)
Publication Details
- Journal
- Advances in Therapy
- Published
- 2025-02-06
- DOI
- https://doi.org/10.1007/s12325-024-03102-6
- Primary Topic
- Hepatitis C virus research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- AbbVie